Medpace
MEDP
82 hedge funds and large institutions have $183M invested in Medpace in 2017 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 18 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 20
28% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 18
6% more funds holding
Funds holding: 77 → 82 (+5)
0.76% less ownership
Funds ownership: 16.25% → 15.49% (-0.76%)
7% less capital invested
Capital invested by funds: $197M → $183M (-$14.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCA
Bernzott Capital Advisors
Camarillo,
California
|
+$9.76M |
| 2 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$7.85M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$6.31M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$6.19M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$5.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$20.9M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$13.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.4M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$11.3M |
| 5 |
PVI
Pura Vida Investments
New York
|
-$4.34M |
MEDP Hedge Fund Activity: Q2 2017 in Review
82 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q2 2017, worth a combined $183M — down 7.2% from $197M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new MEDP positions and 18 closed out — a net gain of 5 holders — while 32 added to existing stakes and 20 trimmed.
The largest buyer was Bernzott Capital Advisors, adding an estimated $9.76M. The largest seller was HealthCor Management, exiting entirely with an estimated $20.9M sold.
- 82 institutional investors held Medpace (MEDP) as of Q2 2017, up from 77 in Q1 2017.
- Funds reported $183M of Medpace stock for Q2 2017, down 7.2% quarter-over-quarter.
- 23 funds opened new Medpace positions in Q2 2017 and 18 closed out, a net change of +5 holders.
- The largest Medpace buyer in Q2 2017 was Bernzott Capital Advisors, an estimated $9.76M added.
- The largest Medpace seller in Q2 2017 was HealthCor Management, an estimated $20.9M sold.
Based on aggregated 13F filings for Q2 2017.